. Author manuscript; available in PMC: 2015 May 1.

Published in final edited form as: J Allergy Clin Immunol Pract. 2014 Feb 16;2(3):294–299.e1. doi: 10.1016/j.jaip.2013.11.009

Table II.

Univariate analysis of ED management and patient disposition based on order set use

Characteristic	All Patients (N= 202) No. (%)	Order Set		P value OR (95%CI)
Characteristic	All Patients (N= 202) No. (%)	Before implementation (N= 48) No. (%)	After implementation (N=154) No. (%)	P value OR (95%CI)
Use of epinephrine in ED	94 (47)	16 (33)	78 (51)	0.04, 2.05 (1.04- 4.04)
ED disposition
Home	39 (19)	14 (29)	25 (16)	0.05, 0.47 (0.22-1.00)
Observation unit	121 (60)	21 (44)	100 (65)	0.009, 2.38 (1.23- 4.60)
General Hospital floor	11 (6)	4 (8)	7 (5)	0.30, 0.52 (0.15- 1.87)
Intensive Care Unit	31 (15)	9 (19)	22 (14)	0.45, 0.72 (0.31- 1.70)
General floor or ICU	42 (21)	13 (27)	29 (19)	0.22, 0.62 (0.29- 1.33)
Outcome
SIE prescription	121 (60)	26 (54)	95 (62)	0.35, 1.36 (0.71- 2.62)
Allergist follow-up	86 (43)	21 (44)	65 (42)	0.85, 0.94 (0.49- 1.81)

CI: Confidence Interval, ED: Emergency Department, ICU: Intensive Care Unit, OR: Odds ratio, SIE: self-injectable epinephrine.